Olympus broadens endoscopy spectrum with Quest acquisition 02 Feb 2021 Industrial and medical imaging company Olympus is set to broaden the capability of its endoscopy offering significantly, with the acquisition of Netherlands-headquartered Quest Photonic Devices. Established back in 1998 as Quest Innovations, the Middenmeer-based company specializes in fluorescence and multispectral techniques for applications including better visualization of tumor margins during cancer surgery. Tokyo-based Olympus, which has recently pivoted away from consumer cameras to focus on medical and industrial vision technologies, is acquiring Quest for â¬50 million. According to local media reports (see below), Quest founder and CEO Richard Meester will remain with the company, which will operate as an independent entity within Olympus. Meester also expects Quest to grow significantly from its current roster of 35 employees.